Here are four things to know:
• The stock was sold at an average price of $45.52, for a total transaction of $360,518.
• Mr. Miles now directly owns 91,688 shares in the company, valued at approximately $4,173,637.
• The company’s stock currently has an average rating of “buy” and an average price target of $52.27.
• NuVasive has a 52-week low of $31.35 and a 52-week high of $51.23.
More articles on devices:
DOJ extends Biomet’s deferred prosecution agreement
Oppenheimer updates Globus Medical price target — 5 key notes
Are Medtronic shares undervalued at $77 per share? 7 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
